Anling Hu

415 total citations
27 papers, 277 citations indexed

About

Anling Hu is a scholar working on Molecular Biology, Immunology and Hematology. According to data from OpenAlex, Anling Hu has authored 27 papers receiving a total of 277 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 7 papers in Immunology and 6 papers in Hematology. Recurrent topics in Anling Hu's work include Traditional Chinese Medicine Analysis (3 papers), Angiogenesis and VEGF in Cancer (3 papers) and Cancer-related molecular mechanisms research (3 papers). Anling Hu is often cited by papers focused on Traditional Chinese Medicine Analysis (3 papers), Angiogenesis and VEGF in Cancer (3 papers) and Cancer-related molecular mechanisms research (3 papers). Anling Hu collaborates with scholars based in China, Canada and United States. Anling Hu's co-authors include Jie Liu, Shangfu Xu, Qin Wu, Lu Xie, Jiajia Liu, Yaacov Ben‐David, Wuling Liu, Babu Gajendran, Huan Li and Ce Chen and has published in prestigious journals such as International Journal of Molecular Sciences, Frontiers in Immunology and Biochemical Pharmacology.

In The Last Decade

Anling Hu

25 papers receiving 272 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anling Hu China 10 134 46 32 29 25 27 277
Lihong Wang China 10 166 1.2× 60 1.3× 35 1.1× 14 0.5× 48 1.9× 14 384
Guang Zhao China 12 96 0.7× 25 0.5× 26 0.8× 46 1.6× 13 0.5× 23 395
P. M. Gopinath India 12 184 1.4× 17 0.4× 73 2.3× 35 1.2× 24 1.0× 42 451
Hailun Gu China 12 203 1.5× 38 0.8× 30 0.9× 33 1.1× 75 3.0× 19 489
Xue Tian China 12 130 1.0× 14 0.3× 24 0.8× 27 0.9× 40 1.6× 27 282
Nurkan Aksoy Türkiye 9 84 0.6× 71 1.5× 20 0.6× 72 2.5× 16 0.6× 17 384
Shu-Dong Qiu China 12 197 1.5× 23 0.5× 16 0.5× 22 0.8× 57 2.3× 23 489
Shirlette G. Milton United States 9 228 1.7× 23 0.5× 37 1.2× 18 0.6× 33 1.3× 16 404
Songjiang Yin China 11 301 2.2× 29 0.6× 28 0.9× 20 0.7× 62 2.5× 21 518
Maedeh Hamzeh Iran 9 72 0.5× 46 1.0× 22 0.7× 23 0.8× 23 0.9× 14 363

Countries citing papers authored by Anling Hu

Since Specialization
Citations

This map shows the geographic impact of Anling Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anling Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anling Hu more than expected).

Fields of papers citing papers by Anling Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anling Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anling Hu. The network helps show where Anling Hu may publish in the future.

Co-authorship network of co-authors of Anling Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Anling Hu. A scholar is included among the top collaborators of Anling Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anling Hu. Anling Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Yaoliang, Chunlin Wang, Wuling Liu, et al.. (2024). The Astragalus Membranaceus Herb Attenuates Leukemia by Inhibiting the FLI1 Oncogene and Enhancing Anti-Tumor Immunity. International Journal of Molecular Sciences. 25(24). 13426–13426.
2.
Wang, Chunlin, Wuling Liu, Anling Hu, et al.. (2024). An intricate regulatory circuit between FLI1 and GATA1/GATA2/LDB1/ERG dictates erythroid vs. megakaryocytic differentiation. Molecular Medicine Reports. 29(6). 4 indexed citations
3.
Ran, Xiaojuan, Anling Hu, Chunlin Wang, et al.. (2024). UM171 suppresses breast cancer progression by inducing KLF2. Breast Cancer Research and Treatment. 207(2). 405–415. 1 indexed citations
4.
Wang, Jie, Chunlin Wang, Anling Hu, et al.. (2024). FLI1 induces erythroleukemia through opposing effects on UBASH3A and UBASH3B expression. BMC Cancer. 24(1). 326–326. 4 indexed citations
5.
Gao, Jian, Chunlin Wang, Wuling Liu, et al.. (2023). FLI1 Regulates Histamine Decarboxylase Expression to Control Inflammation Signaling and Leukemia Progression. Journal of Inflammation Research. Volume 16. 2007–2020. 5 indexed citations
6.
Gao, Jian, Fang Yu, Chunlin Wang, et al.. (2023). Lovastatin inhibits erythroleukemia progression through KLF2-mediated suppression of MAPK/ERK signaling. BMC Cancer. 23(1). 306–306. 5 indexed citations
7.
Xu, Shangfu, Anling Hu, Taotao Liu, et al.. (2023). The role of calcium-sensing receptor in ginsenoside Rg1 promoting reendothelialization to inhibit intimal hyperplasia after balloon injury. Biomedicine & Pharmacotherapy. 163. 114843–114843. 1 indexed citations
8.
Liu, Wuling, Babu Gajendran, Klarke M. Sample, et al.. (2022). A critical ETV4/Twist1/Vimentin axis in Ha-RAS-induced aggressive breast cancer. Cancer Gene Therapy. 29(11). 1590–1599. 2 indexed citations
9.
Chen, Beiling, Chunlin Wang, Xiao Xiao, et al.. (2022). FLI1 accelerates leukemogenesis through transcriptional regulation of pyruvate kinase-L/R and other glycolytic genes. Medical Oncology. 40(2). 69–69. 4 indexed citations
10.
Hu, Anling, Jian Gao, Babu Gajendran, et al.. (2022). UM171 cooperates with PIM1 inhibitors to restrict HSC expansion markers and suppress leukemia progression. Cell Death Discovery. 8(1). 448–448. 4 indexed citations
11.
Chen, Beiling, Chunlin Wang, Wuling Liu, et al.. (2022). FLI1 regulates inflammation-associated genes to accelerate leukemogenesis. Cellular Signalling. 92. 110269–110269. 9 indexed citations
12.
Xiao, Xiao, Philip E.D. Chung, Mei Xu, et al.. (2022). A racemosin B derivative, C25, suppresses breast cancer growth via lysosomal membrane permeabilization and inhibition of autophagic flux. Biochemical Pharmacology. 201. 115060–115060. 2 indexed citations
13.
Liu, Wuling, Jialei Song, Chunlin Wang, et al.. (2021). An immunotherapeutic approach to decipher the role of long non-coding RNAs in cancer progression, resistance and epigenetic regulation of immune cells. Journal of Experimental & Clinical Cancer Research. 40(1). 242–242. 11 indexed citations
14.
Hu, Mi, Xu‐Jie Qin, Qing Rao, et al.. (2021). A natural acylphloroglucinol triggered antiproliferative possessions in HEL cells by impeding STAT3 signaling and attenuating angiogenesis in transgenic zebrafish model. Biomedicine & Pharmacotherapy. 141. 111877–111877. 7 indexed citations
15.
Wang, Chunlin, Klarke M. Sample, Babu Gajendran, et al.. (2021). FLI1 Induces Megakaryopoiesis Gene Expression Through WAS/WIP-Dependent and Independent Mechanisms; Implications for Wiskott-Aldrich Syndrome. Frontiers in Immunology. 12. 607836–607836. 18 indexed citations
16.
Liu, Jiajia, et al.. (2020). Xiaochaihutang Improves the Cortical Astrocyte Edema in Thioacetamide-Induced Rat Acute Hepatic Encephalopathy by Activating NRF2 Pathway. Frontiers in Pharmacology. 11. 382–382. 25 indexed citations
17.
Hu, Anling, Sheng Song, Yi Li, et al.. (2020). Mercury sulfide-containing Hua-Feng-Dan and 70W (Rannasangpei) protect against LPS plus MPTP-induced neurotoxicity and disturbance of gut microbiota in mice. Journal of Ethnopharmacology. 254. 112674–112674. 21 indexed citations
18.
Zhang, Bin-Bin, Yongmei Liu, Anling Hu, et al.. (2019). HgS and Zuotai differ from HgCl2 and methyl mercury in intestinal Hg absorption, transporter expression and gut microbiome in mice. Toxicology and Applied Pharmacology. 379. 114615–114615. 21 indexed citations
19.
Chen, Ce, Bin‐Bin Zhang, Anling Hu, et al.. (2019). Protective role of cinnabar and realgar in Hua-Feng-Dan against LPS plus rotenone-induced neurotoxicity and disturbance of gut microbiota in rats. Journal of Ethnopharmacology. 247. 112299–112299. 34 indexed citations
20.
Hu, Anling, Yingying Li, Juan Huang, et al.. (2019). Naringenin attenuates carotid restenosis in rats after balloon injury through its anti-inflammation and anti-oxidative effects via the RIP1-RIP3-MLKL signaling pathway. European Journal of Pharmacology. 855. 167–174. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026